ArticleRSC advances2024
Design and application of histidine-functionalized ZnCr-LDH nanozyme for promoting bacteria-infected wound healing.
Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 12 citations in OpenAlex.
- Stimuli-responsive nanozymes for wound healing: From design strategies to therapeutic advances.Materials today. Bio · 2025Review
- New emerging materials with potential antibacterial activities.Applied microbiology and biotechnology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excessive use of antibiotics can lead to an increase in antibiotic-resistant bacteria, which makes it a serious health threat. Therefore, developing new materials with antibacterial activity, such as nanozymes, has gained considerable attention. Reactive oxygen species (ROS) produced by nanozymes have rapid and effective antibacterial efficacy. Here, histidine (His) modified ZnCr layered double hydroxide (LDH) was synthesized inspired by the natural enzyme, and the enzyme-like activity of His/ZnCr-LDH was tested using a colorimetric method. Then, we developed an acid-enhanced antibacterial method based on the high peroxidase-like activity of His/ZnCr-LDH, and its ROS-generating capability in the presence of glucose oxidase (GOx) and glucose (Glu) as a source of hydrogen peroxide (H
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.